Clinical Trials Browser

Phase 2 × peginterferon alfa-2a × Dermatologic × Clear all

NCT02218164 2022-10-07

Capecitabine or 5-FU With Pegylated Interferon Alpha-2b in Unresectable/Metastatic Cutaneous Squamous Cell Carcinoma

Phase 2 Completed

8 enrolled 11 charts

Carcinoma, Squamous Cell, Neoplasm Metastasis, Skin Neoplasms